Veterinary Medicines

Belacol 100 % Compactate

Authorised
  • COLISTIN SULFATE
Download as PDF

Product identification

Medicine name:
Belacol 100 % Compactate
Belacol 100 % Compactate 1000 mg/g granulas lietošanai dzeramajā ūdenī liellopiem, cūkām un vistām
Active substance:
  • COLISTIN SULFATE
Target species:
  • Cattle
  • Chicken
  • Pig
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • COLISTIN SULFATE
    1000.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Granules for use in drinking water
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Cattle
      • Meat and offal
        1
        day
    • Chicken
      • Meat and offal
        1
        day
    • Pig
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Available in:
  • Latvia
Package description:
  • 1 kg in fold-up carton with inner layer (paper/PE/Alu/PE)
  • 250 g in fold-up carton with inner layer (paper/PE/Alu/PE)
  • 2.5 kg in kard-o-seal-bag (PE/paper/PE/Alu/PE)
  • 500 g in fold-up carton with inner layer (paper/PE/Alu/PE)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/16/0027
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0199/001
Concerned member states:
  • Croatia
  • Estonia
  • Greece
  • Hungary
  • Latvia
  • Lithuania
  • Slovakia
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."